These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 2733994)

  • 21. Management of proliferative diabetic retinopathy.
    Gündüz K; Bakri SJ
    Compr Ophthalmol Update; 2007; 8(5):245-56. PubMed ID: 18201511
    [TBL] [Abstract][Full Text] [Related]  

  • 22. 23-gauge vitrectomy in 100 eyes: short-term visual outcomes and complications.
    Lott MN; Manning MH; Singh J; Zhang H; Singh H; Marcus DM
    Retina; 2008 Oct; 28(9):1193-200. PubMed ID: 18626419
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Incidence of endophthalmitis after 20- and 25-gauge vitrectomy causes and prevention.
    Shimada H; Nakashizuka H; Hattori T; Mori R; Mizutani Y; Yuzawa M
    Ophthalmology; 2008 Dec; 115(12):2215-20. PubMed ID: 18930557
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Diabetic vitrectomy: influence of lens status upon anatomic and visual outcomes.
    Schiff WM; Barile GR; Hwang JC; Tseng JJ; Cekiç O; Del Priore LV; Chang S
    Ophthalmology; 2007 Mar; 114(3):544-50. PubMed ID: 17169431
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Complications of vitrectomy for non-clearing vitreous hemorrhage in diabetic patients.
    Benson WE; Brown GC; Tasman W; McNamara JA
    Ophthalmic Surg; 1988 Dec; 19(12):862-4. PubMed ID: 3231410
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Changes in vitreous concentrations of human hepatocyte growth factor (hHGF) in proliferative diabetic retinopathy: implications for intraocular hHGF production.
    Nishimura M; Ikeda T; Ushiyama M; Kinoshita S; Yoshimura M
    Clin Sci (Lond); 2000 Jan; 98(1):9-14. PubMed ID: 10600653
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Outcome of diabetic vitrectomy in Latino population.
    Flaxel CJ; Dustin L; Kim J; Bekendam P; Row P
    Retina; 2007; 27(9):1274-8. PubMed ID: 18046237
    [TBL] [Abstract][Full Text] [Related]  

  • 28. En bloc perfluorodissection for tractional retinal detachment in proliferative diabetic retinopathy.
    Arevalo JF
    Ophthalmology; 2008 Jun; 115(6):e21-5. PubMed ID: 18423870
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Transconjunctival 25-gauge sutureless vitrectomy and silicone oil injection in diabetic tractional retinal detachment.
    Altan T; Acar N; Kapran Z; Unver YB; Ozdogan S
    Retina; 2008 Oct; 28(9):1201-6. PubMed ID: 18728620
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Should associated intraoperative and/or postoperative photocoagulation be systematic during or after vitrectomy for proliferative diabetic vitreoretinopathy?].
    Hajji Z; Rouillot JS; Roth P; Grange JD
    J Fr Ophtalmol; 2003 Jan; 26(1):47-53. PubMed ID: 12610409
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Early vitrectomy for severe vitreous hemorrhage in diabetic retinopathy. Four-year results of a randomized trial: Diabetic Retinopathy Vitrectomy Study Report 5.
    Arch Ophthalmol; 1990 Jul; 108(7):958-64. PubMed ID: 2196036
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Acute vitreous hemorrhage in diabetes--clinical aspects and follow-up].
    Winter R; Guthoff R; Knüppel V
    Klin Monbl Augenheilkd; 1986 Nov; 189(5):391-3. PubMed ID: 3807237
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Current management of vitreous hemorrhage due to proliferative diabetic retinopathy.
    El Annan J; Carvounis PE
    Int Ophthalmol Clin; 2014; 54(2):141-53. PubMed ID: 24613890
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Procoagulant effects of intraocular sodium hyaluronate (Healon) after phakic diabetic vitrectomy. A prospective, randomized study.
    Packer AJ; McCuen BW; Hutton WL; Ramsay RC
    Ophthalmology; 1989 Oct; 96(10):1491-4. PubMed ID: 2685709
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Thrombin infusion for the control of intraocular bleeding during vitreous surgery.
    de Bustros S; Glaser BM; Johnson MA
    Arch Ophthalmol; 1985 Jun; 103(6):837-9. PubMed ID: 4004626
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Vitrectomy for vitreous hemorrhage in Chinese diabetic patients.
    Ho PC
    Yan Ke Xue Bao; 1985 Dec; 1(2):148-50. PubMed ID: 3880147
    [No Abstract]   [Full Text] [Related]  

  • 37. [Use of thrombin in the prevention and arrest of intraocular hemorrhage during vitrectomy in traumatic hemophthalmos].
    Danilov AV; Gorbunov AA; Kuznetsova LV
    Vestn Oftalmol; 1990; 106(4):36-9. PubMed ID: 2238322
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Thrombin infusion to control bleeding during vitrectomy for stage V retinopathy of prematurity.
    Blacharski PA; Charles ST
    Arch Ophthalmol; 1987 Feb; 105(2):203-5. PubMed ID: 3813950
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Vitreous hemorrhage and the Valsalva maneuver in proliferative diabetic retinopathy.
    Kassoff A; Catalano RA; Mehu M
    Retina; 1988; 8(3):174-6. PubMed ID: 3231911
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Intraocular infusate with hemocoagulase for the control of bleeding during vitreous surgery.
    Lee HS; Kim SH; Kim IT
    Korean J Ophthalmol; 1989 Jun; 3(1):6-10. PubMed ID: 2795941
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.